Streptozotocin upregulates GAD67 expression in MIN6N8a mouse beta cells

Journal of Autoimmunity

Volumn 19, Issue 1-2, 2002, Pages 1-8

  Choi, Sung E ^a   Noh, Hye Lim ^a   Kim, Hyeon Man ^a   Yoon, Ji Won ^b   Kang, Yup ^a  

^a Ajou University School of Medicine   (South Korea)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoantigen; Beta cell; Glutamic acid decarboxylase (GAD); NF B; Streptozotocin

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN P53; STREPTOZOCIN; ANTIINFECTIVE AGENT; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE 67;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; CULTURE MEDIUM; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; ANIMAL; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PANCREAS ISLET; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; AUTOANTIGENS; DIABETES MELLITUS, EXPERIMENTAL; GLUTAMATE DECARBOXYLASE; ISLETS OF LANGERHANS; ISOENZYMES; MICE; NAD; NF-KAPPA B; STREPTOZOCIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0036700969     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0602     Document Type: Article

References (49)

1. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. 1991. Two genes encode distinct glutamate decarboxylase. Neuron 7: 91-100
2. Kaufman D.L., Houser C.R., Tobin A.J. 1991. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56(2): 720-723
3. Kim J., Richter W., Aanstoot H.J., Shi Y., Fu Q., Rajotte R., Warnock G., Baekkeskov S. 1993. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets. Diabetes 42: 1799-1808
4. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P., Camilli P.D. 1990. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
5. Atkinson M.A., Maclaren N.K. 1988. Autoantibodies in nonobese diabetic mice immunoprecipitate 64,000-Mr islet antigen. Diabetes 37: 1587-1590
6. Baekkeskov S., Kanaani J., Jaume J.C., Kash S. 2000. Does GAD have a unique role in triggering IDDM? J. Autoimmun. 15(3): 279-286
7. Yoon J.W., Sherwin R.S., Kwon H.J., Jun H.S. 2000. Has GAD a central role in Type 1 diabetes? J. Autoimmun. 15: 273-278
8. Wen L., Wong F.S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R., Sherwin R.S. 1998. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4+ T cells from human DQ transgenic mice? J. Clin. Invest. 102(5): 947-957
9. Zekzer D., Wong F.S., Ayalon O., Millet I., Altieri M., Shintani S., Solimena M., Sherwin R.S. 1998. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101: 68-73
10. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E., Tobin A.J., Lehmann P.V. 1993. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin dependent diabetes. Nature 366: 69-72
11. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366: 72-75
12. Bridgett M., Cetkovic-Cvrlje M., O'Rourke R., Shi Y., Narayanswami S., Lambert J., Ramiya V., Baekkeskov S., Leiter E.H. 1998. Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in the pancreatic β-cells. Diabetes 47(12): 1848-1856
13. Yoon J.W., Yoon C.S., Lim H.W., Huang Q.Q., Kang Y., Pyun K.H., Hirasawa K., Sherin R.S., Jun H.S. 1999. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in b cells. Science 284: 1183-1187
14. Kash S.F., Condie B.G., Baekkeskov S. 1999. Glutamate decarboxylase and GABA in pancreatic islets: Lessons from knock-out mice. Hor. Met. Res. 31: 340-344
15. Rubi B., Ishihara H., Hegardt F.G., Wollheim C.B., Maechler P. 2001. GAD65-mediated glutamate decarboxylation reduces glucose-stimulated insulin secretion in pancreatic beta cells. J. Biol. Chem. 276: 36391-36396
16. Hao W., Li L., Mehta V., Lernmark A., Palmer J.P. 1994. Functional state of the β cell affects expression of both forms of glutamic acid decarboxylase. Pancreas 9(5): 558-562
17. Degli Esposti M., Mackay I.R. 1997. The GABA network and the pathogenesis of IDDM. Diabetologia 40: 352-356
18. Katoh J., Taniguchi H., Kasuga M. 1995. Response of glutamic acid decarboxylase to glucose but not arginine in islets. Life Sci. 56(21): 1799-1805
19. Sanchez-Soto M.C., Larrieta M.E., Vidaltamayo R., Hiriart M. 1999. Heterogeneity in glutamic acid decarboxylase expression among single rat pancreatic beta cells. Diabetologia 42: 1086-1092
20. Petersen J.S., Rimvall K., Jorgensen P.N., Hasselager E., Moody A., Hejnaes K., Clausen J.T., Dytberg T. 1998. Regulation of GAD expression in rat pancreatic islets and brain by γ-vinyl-GABA and glucose. Diabetologia 41: 530-535
21. Mally M.I., Cirulli V., Otonkoski T., Soto G., Hayek A. 1996. Ontogeny and tissue distribution of human GAD expression. Diabetes 45: 496-501
22. Pleau J.M., Throsby M., Esling A., Dardenne M. 1997. Ontogeny of glutamic acid decarboxylase gene expression in the mouse pancreas. Biochem. Biophys. Res. Commun. 233: 227-230
23. Hao W., Palmer J.P. 1995. The effect of cytokines on expression of glutamic acid decarboxylase-65 in cultured islets. Autoimmunity 22(4): 209-218
24. Weiss R.B. 1982. Streptozotocin: a review of its pharmacology, efficacy, and toxicity. Cancer treat. Rep. 66(3): 427-438
25. Schein P.S., O'Connell M.J., Blom J., Hubbard S., Magrath I.T., Bergevin P., Wiernik P.H., Zeiegler J.L., DeVita V.T. 1974. Clinical antitumor and toxicity of streptozotocin (NSC-85998). Cancer 34(4): 993-1000
26. Turk J., Corbett J.A., Ramanadham S., Bohrer A., McDaniel M.L. 1993. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197(3): 1458-1464
27. Ohly P., Dohle C., Abel J., Seissler J., Gleichmann H. 2000. Zinc sulfate induces metallothionein in pancreatic islet of mice and protects against diabetes induced by multiple low doses of streptozotocin. Diabetologia 43(8): 1020-1030
28. Lenzen S., Tiedge M., Jorns A., Munday R. 1996. Alloxan derivative as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. In Lessons from Animal Diabetes E. Shafrir, ed. Birkhauser, Boston, pp. 113-122
29. Elias D., Prigozin H., Polak N., Rapoport M., Lohse A.W., Cohen I.R. 1994. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 43: 992-998
30. Preston A.M. 1985. Modification of streptozotocin-induced diabetes by protective agents. Nutr. Res. 5: 435-446
31. Murata M., Takahashi A., Saito I., Kawanishi S. 1999. Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem. Pharmacol. 57: 881-887
32. Uchigata Y., Yamamoto H., Kawamura A., Okamoto H. 1982. Protection by superoxide dismutase, catalase, and poly (ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem. 257(11): 6084-6088
33. Pieper A.A., Brat D.J., Krug D.K., Watkins C.C., Gupta A., Blackshaws S., Vermat A., Wang Z.Q., Snyder S.H. 1999. Poly (ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96(6): 3059-3064
34. Masutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T., Jishage K., Watanabe T., Sugimoto T., Nakagama H., Ochita T., Sugimura T. 1999. Poly (ADP-ribose) polymerase gene destruction conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96(5): 2301-2304
35. Burkart V., Wang Z.Q., Radons J., Heller B., Herceg Z., Stingl L., Wagner E.F., Kolb H. 1999. Mice lacking the poly (ADP-ribose) polymerase gene are resistant to pancreatic beta cell destruction and diabetes development induced by streptozotocin. Nat. Med. 5(3): 314-319
36. Agarwal M.L., Taylor W.R., Chernov M.V., Chernova O.B., Stark G.R. 1998. The p53 network. J. Biol. Chem. 273: 1-4
37. Tiedge M., Lortz S., Drinkgern J., Lenzen S. 1997. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742
38. Elsner M., Guldbakke B., Tiedge M., Munday R., Lenzen S. 2000. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533
39. Pahl H.L. 1999. Activators and targets genes of Rel/NF-κB transcription factors. Oncogene 18(49): 6853-6866
40. Epinat J.C., Gilmore T.D. 1999. Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway. Oncogene 18(49): 6896-6909
41. Saini K.S., Thompson C., Winterford C.M., Walker N.I., Cameron D.P. 1996. Streptozotocin at low does induces apoptosis and at high doses causes necrosis in a murine pancreatic beta cell line, INS-1. Biochem. Mol. Biol. Int. 39(6): 1229-1236
42. Li P.F., Dietz R., von Harsdorf R. 1999. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18(21): 6027-6036
43. Deng L., Lee Y-C., Claret F-X., Kuo M.T. 2000. 2-Acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-κB pathway. J. Biol. Chem. 276(1): 413-420
44. Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. 2000. Role of NF-κB in p53-mediated programmed cell death. Nature 404: 892-897
45. Ho E., Chen G., Bray T.M. 1999. Supplementation of N-acetylcysteine inhibits NF-κB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J. 13(13): 1845-1854
46. Szabo G., Katarova Z., Kortvely E., Greenspan R.J., Urban Z. 1996. Structure and the promoter region of the mouse gene encoding the 67-kD form of glutamic acid decarboxylase. DNA Cell. Biol. 15(12): 1081-1091.
47. Myers M.A., Georgiou H.M., Byron S., Esporti M.D. 1999. Inhibition of mitochondrial oxidative phosphorylation induces hyper-expression of glutamic acid decarboxylase in pancreatic islet cells. Autoimmunity 30: 43-51
48. Kroemer G., Reed J.C. 2000. Mitochondrial control of cell death. Nat. Med. 6(5): 513-519
49. Hou J., Sheikh S., Martin D.L., Chatterjee N.K. 1993. Coxsackievirus B4 alters pancreatic glutamate decarboxylase expression in mice soon after infection. J. Autoimmunity 6(5): 529-542